Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 23, 1999 - Issue 4
72
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Hb Aghia Sophia [α62(E11)Val→0 (α1)], an “In-Frame” Deletion Causing α-Thalassemia

, , , , &
Pages 317-324 | Received 27 May 1999, Accepted 21 Jun 1999, Published online: 07 Jul 2009
 

Abstract

In this report we describe a case of Hb H disease due to the interaction of the -(MEDI) deletion with a new (α+-thalassemia determinant. The molecular analysis of the proband's genomic DNA was carried out by polymerase chain reaction amplification and sequencing of both α genes of the α+-thalassemia chromosome and revealed a deletion of codon 62 of the α1 gene. This DNA triplet codes for a valine residue at the E11 α helix, which is located in the interior of the heme pocket. Substitutions of valine E11 with other amino acid residues in the α as well as β polypeptide chains lead, in the heterozygous carrier, either to Hb M disease or to congenital non-spherocytic hemolytic anemia. We assume that the deletion of valine at α62(E11) disrupts the conformation of the α chain to such an extent that the mutated subunit is rapidly removed by proteolysis. The final result is an α-thalassemia phenotype rather than an unstable hemoglobin syndrome. This conclusion is supported by the apparent absence of an abnormal α chain in the peripheral blood of the patient.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.